Skip to main content

IBM Watson Health and Broad Institute Launch Major Research Initiative to Study Why Cancers Become Drug Resistant

  • IBM Watson Health and Broad Institute Launch Major Research Initiative to Study Why Cancers Become Drug Resistant

    IBM Watson Health and Broad Institute Launch Major Research Initiative to Study Why Cancers Become Drug Resistant

    Date added: 10 Nov 2016

    IBM Watson Health and the Broad Institute bring the data prowess of Watson to study cancer drug resistance in a $50M research collaboration. The goal is to identify patterns that could reveal clues into one of the greatest medical mysteries of cancer. Ultimately, scientists hope to use knowledge about how cancers become resistant to create combination therapies that prevent resistance from occurring. (Courtesy of the Broad Institute)